Related Articles
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
PD‑L1 expression in malignant melanomas of the skin and gastrointestinal tract
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report